GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » 3-Year Share Buyback Ratio

CVSI (CV Sciences) 3-Year Share Buyback Ratio : -17.90% (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is CV Sciences 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. CV Sciences's current 3-Year Share Buyback Ratio was -17.90%.

The historical rank and industry rank for CV Sciences's 3-Year Share Buyback Ratio or its related term are showing as below:

CVSI' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -86.6   Med: -19.9   Max: -3.6
Current: -17.9

During the past 13 years, CV Sciences's highest 3-Year Share Buyback Ratio was -3.60%. The lowest was -86.60%. And the median was -19.90%.

CVSI's 3-Year Share Buyback Ratio is ranked worse than
81.58% of 673 companies
in the Drug Manufacturers industry
Industry Median: -2.9 vs CVSI: -17.90

Competitive Comparison of CV Sciences's 3-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CV Sciences's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CV Sciences's 3-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CV Sciences's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where CV Sciences's 3-Year Share Buyback Ratio falls into.


;
;

CV Sciences 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


CV Sciences (OTCPK:CVSI) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


CV Sciences 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of CV Sciences's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CV Sciences Business Description

Traded in Other Exchanges
N/A
Address
9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126
CV Sciences Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The Company sells its products under tradenames, such as +PlusCBD, PlusCBD Pet, lusHLTH, Cultured Foods, and Lunar Fox. The Company's products are sold in a variety of market sectors, including nutraceutical, beauty care, and specialty foods. The company's hemp-based products are predominantly sold in Europe and in the retail space. The company generates revenue from Retail Sales and E-Commerce sales of its product.
Executives
William Mccorkle director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr. director 9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md director 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake director 145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay officer: Sr VP Scientific/Regulatory 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling officer: Chief Financial Officer 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser officer: CFO 2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham director C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty director C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin director 1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc. other: Member 10% holding group 6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118